M&A Deal Summary

ADMA Biologics Acquires Biotest Pharmaceuticals - US Therapy Business

On January 23, 2017, ADMA Biologics acquired life science company Biotest Pharmaceuticals - US Therapy Business from Biotest Pharmaceuticals for 40M USD

Acquisition Highlights
  • This is ADMA Biologics’ 1st transaction in the Life Science sector.
  • This is ADMA Biologics’ largest (disclosed) transaction.
  • This is ADMA Biologics’ 1st transaction in the United States.

M&A Deal Summary
Date 2017-01-23
Target Biotest Pharmaceuticals - US Therapy Business
Sector Life Science
Buyer(s) ADMA Biologics
Sellers(s) Biotest Pharmaceuticals
Deal Type Divestiture
Deal Value 40M USD

Target

Biotest Pharmaceuticals - US Therapy Business

United States
Biotest Pharmaceuticals Corp. - US Therapy Business Includes the assets of BPC’s plasma fractionation facility, its commercial products, contract manufacturing agreements as well as BPC’s Boca Raton, Florida headquarters and real properties.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ADMA Biologics

Ramsey, New Jersey, United States
Category Company
Founded 2004
Sector Life Science
Employees624
Revenue 258M USD (2023)
DESCRIPTION

ADMA Biologics is a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the proposed treatment of Immune Deficiencies and the prevention and treatment of certain infectious diseases. ADMA's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. ADMA Biologics was founded in 2004 and is based in Ramsey, New Jersey.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Biotest Pharmaceuticals

Boca Raton, Florida, United States
Category Company
Founded 2007
Sector Life Science
DESCRIPTION

Biotest Pharmaceuticals researches and manufactures biotherapeutic products with a specialization in immunology and hematology. Biotest Pharmaceuticals is a leader in the collection of source plasma and is currently involved in the development of plasma protein products in the field of Primary Immune Deficiency (PID) and various hyperimmune (IG) products which are antibody specific to high titer for treatment of modality.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (United States) 1 of 1
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal